Article

Download article
Title: Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections
Author: Miguel, D. C.; Zauli-nascimento, R. C.; Yokoyama-yasunaka, J. K. U.; Katz, S.; Barbieri, C. L.; Uliana, S. R. B.
Year: 2009
Is part of: Journal of Antimicrobial Chemotherapy (Print), v. 63, p. 365 - 368
DOI: https://doi.org/10.1093/jac/dkn509

Citation: Miguel, D. C.; Zauli-nascimento, R. C.; Yokoyama-yasunaka, J. K. U.; Katz, S.; Barbieri, C. L.; Uliana, S. R. B.; Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Journal of Antimicrobial Chemotherapy (Print), v.63, p. 365-368, 2009

Abstract: The aim of this study was to evaluate the efficacy of tamoxifen in vivo in experimental models of cutaneous (CL) and visceral leishmaniasis (VL) caused by Leishmania braziliensis and Leishmania chagasi, respectively.



Funding: This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). D. C. M. and R. C. Z.-N. were supported by FAPESP and CNPq fellowships, respectively.
Financed by: